ArTS Archivio della ricerca di Trieste

CONFALONIERI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.138
NA - Nord America 4.076
EU - Europa 3.114
SA - Sud America 447
AF - Africa 146
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.886
SG - Singapore 1.335
IT - Italia 1.191
CN - Cina 850
VN - Vietnam 493
HK - Hong Kong 405
BR - Brasile 337
DE - Germania 279
BD - Bangladesh 273
KR - Corea 264
GB - Regno Unito 225
FR - Francia 210
SE - Svezia 193
NL - Olanda 185
FI - Finlandia 176
PL - Polonia 146
RU - Federazione Russa 115
IN - India 114
CA - Canada 90
IE - Irlanda 69
BG - Bulgaria 60
TR - Turchia 56
MX - Messico 55
AT - Austria 51
JP - Giappone 50
CH - Svizzera 47
MA - Marocco 47
ID - Indonesia 42
IQ - Iraq 36
ES - Italia 35
AR - Argentina 33
UA - Ucraina 32
ZA - Sudafrica 28
AU - Australia 27
PK - Pakistan 24
PH - Filippine 22
SA - Arabia Saudita 22
CO - Colombia 21
BE - Belgio 18
UZ - Uzbekistan 16
EC - Ecuador 15
TH - Thailandia 15
IR - Iran 13
TW - Taiwan 13
CL - Cile 12
CZ - Repubblica Ceca 12
EG - Egitto 12
GR - Grecia 12
SN - Senegal 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
IL - Israele 10
MY - Malesia 10
AZ - Azerbaigian 9
TN - Tunisia 9
NP - Nepal 8
PA - Panama 8
RO - Romania 8
CR - Costa Rica 7
AO - Angola 6
DK - Danimarca 6
JO - Giordania 6
KE - Kenya 6
LK - Sri Lanka 6
LT - Lituania 6
NZ - Nuova Zelanda 6
OM - Oman 6
PT - Portogallo 6
BY - Bielorussia 5
DZ - Algeria 5
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
AL - Albania 4
GT - Guatemala 4
HN - Honduras 4
JM - Giamaica 4
LU - Lussemburgo 4
NG - Nigeria 4
NO - Norvegia 4
PS - Palestinian Territory 4
UY - Uruguay 4
YE - Yemen 4
CI - Costa d'Avorio 3
ET - Etiopia 3
HU - Ungheria 3
LY - Libia 3
BO - Bolivia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
EE - Estonia 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MG - Madagascar 2
PR - Porto Rico 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 11.926
Salva come PNG Salva come JPEG
Città #
Singapore 734
Ashburn 597
San Jose 519
Hong Kong 388
Hefei 259
Seoul 259
Chandler 258
Council Bluffs 258
Trieste 207
Beijing 184
Los Angeles 153
Ho Chi Minh City 149
Dallas 128
Boardman 118
Hanoi 115
New York 107
London 104
Chicago 95
Milan 88
Santa Clara 85
Columbus 82
Lauterbourg 82
Helsinki 70
Lappeenranta 66
Munich 66
Zgierz 66
Frankfurt am Main 64
Dublin 58
Sofia 58
Warsaw 58
Princeton 56
Moscow 55
The Dalles 55
Rome 47
São Paulo 46
Buffalo 44
Turku 36
Naples 35
Tokyo 34
Casablanca 33
Vienna 33
Montreal 32
Denver 30
Manchester 29
Nuremberg 29
Redmond 29
Wilmington 29
Amsterdam 28
Atlanta 26
Bern 25
Dong Ket 25
Haiphong 25
Orem 24
Toronto 24
Düsseldorf 23
Chennai 22
North Bergen 21
Boydton 20
Shanghai 20
Udine 20
Da Nang 19
Florence 19
Redondo Beach 19
Turin 19
Mexico City 18
Mumbai 17
Wroclaw 17
Brussels 16
Paris 16
Phoenix 16
Seattle 16
Baghdad 15
Rio de Janeiro 15
Ankara 14
Berlin 14
Bremen 14
Pordenone 14
Tashkent 14
Adana 13
Barnet 13
Houston 13
Treviso 13
Ann Arbor 12
Brooklyn 12
Dakar 12
Jakarta 12
Johannesburg 12
San Donà di Piave 12
Stockholm 12
Thái Nguyên 12
Woodbridge 12
Guangzhou 11
Redwood City 11
Riyadh 11
Zurich 11
Bangkok 10
Bologna 10
Dhaka 10
Genoa 10
Istanbul 10
Totale 6.976
Salva come PNG Salva come JPEG
Nome #
Alveolar Epithelial Type II Cells 396
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 234
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 215
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 213
Chronic Thromboembolic Pulmonary Hypertension: An Update 213
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 210
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 205
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 204
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 203
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 198
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 197
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 196
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 193
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 192
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 190
The Treatment of Lung Involvement in Systemic Sclerosis 189
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 188
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 184
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 183
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 181
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 179
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 168
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 167
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 165
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 164
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 161
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 159
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 157
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 157
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 155
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 154
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 152
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 150
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 149
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 147
Caution When Comparing the Impact of Corticosteroids in COVID-19 144
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 144
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 143
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 143
Host-Based Treatments for Severe COVID-19 141
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 141
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 141
Comorbidities’ Effect on IPF: Pathogenesis and Management 139
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 138
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 138
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 137
Advances in Diagnostics and Management of Respiratory System Diseases 135
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 134
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 133
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 131
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 130
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 130
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 129
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 127
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 125
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 124
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 122
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 120
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 120
Biomarkers in Systemic Sclerosis: An Overview 119
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 114
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 110
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 104
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 101
Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis 97
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis? 93
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? 93
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19 90
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients 88
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with Polyangiitis. 86
Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations 86
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 84
Indirect evaluation of lung condition by means of LF-NMR following chest physiotherapy or ETI administration in cystic-fibrosis patients 78
Evaluating Nailfold Capillaroscopy as a Diagnostic Tool in EGPA with Pulmonary Involvement 78
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report 77
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update 77
Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids 75
Exploring sarcoidosis via nailfold capillaroscopy: A window into the disease’s microvascular landscape 69
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study 65
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials 64
First evaluation of microvascular damage through nailfold capillaroscopy of an uncommon case of Raynaud's phenomenon in multiple sclerosis: Case report and literature review 60
Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice 57
Sex differences in low arousal threshold in obstructive sleep apnea 57
Editorial for “Diagnosis, Classification, and Monitoring of Pulmonary Diseases” 53
Analyzing Sarcoidosis via Nailfold Capillaroscopy: Microvascular Insights 51
Evaluation of possible risk factor of pulmonary embolism in sarcoidosis patients 49
Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies 45
Ultra-high-resolution synchrotron phase-contrast CT enables microstructural pulmonary imaging at clinical dose levels 44
Evaluation of chronic thromboembolic pulmonary hypertension: a pilot-study 43
Multinational Survey on the Symptom Approach to Diagnosis and Therapy Adopted by Physicians in the Treatment of Gastrointestinal Sarcoidosis 43
Formaldehyde vapour fixation enables multiscale phase-contrast imaging and histological validation of human-sized lungs 43
Existence and relevance of fulminant severe community-acquired pneumonia 43
Investigating Fairness with FanFAIR: is Pre-processing Useful Only for Performances? 39
Trattamenti dell’ipertensione polmonare tromboembolica cronica (CTEPH): uno studio pilota 35
Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes 12
Effectiveness of Desensitization Therapy for Grasses and Dust Mites on Asthma Exacerbations and Respiratory Function During the Allergy Season: A Pilot Study 3
Totale 12.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022489 43 12 28 57 39 13 32 14 72 35 41 103
2022/2023942 79 112 94 90 78 117 29 85 119 24 75 40
2023/20241.074 70 48 81 74 108 92 223 134 39 47 96 62
2024/20252.318 59 129 173 206 187 168 137 127 249 337 234 312
2025/20267.280 603 387 521 723 569 553 945 291 816 885 605 382
Totale 12.302